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expression of the CD4 and CD8 coreceptors is regulated
therefore may also provide insight into molecular pro-
cesses involved in lineage commitment.
The major regulatory elements governing the expres-
sion of murine CD4 have been shown to consist of a
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T cell±specific enhancer located approximately 13 kbNew York University Medical Center
upstream of the transcription start site (Sawada andNew York, New York 10016
Littman, 1991) and a lineage-specific silencing element
residing within the first intron of CD4 (Sawada et al.,
1994; Siu et al., 1994). The elements regulating the ex-Summary
pression of CD8 in vivo are not known. Thymus-derived
T cells generally express CD8a and CD8b heterodimersPositive selection of CD41CD81 T cells to the
on their surface, whereas extrathymically derived intra-CD41CD82 helper and CD42CD81 cytotoxic lineages
epithelial lymphocytes (IEL) and a subset of human natu-is a multistep process that involves complex regula-
ral killer (NK) cells express only CD8aa homodimerstion of coreceptor gene expression. By analyzing ex-
(Jarry et al., 1990; Lefrancois, 1991; Moebius et al.,pression of a reporter gene in transgenic mice, we
1991). This indicates that the expression of the CD8ahave identified a DNA segment, located between the
and CD8b genes, which are linked at a distance of aboutmurine CD8b and CD8a genes, that has enhancer ac-
36 kb on mouse chromosome 6 (Gorman et al., 1988),tivity restricted to CD8 lineage cells. Remarkably, this
must be both coordinately and independently regulated.enhancer functions in thymocytes undergoing positive
In addition, since CD4 is transcriptionally silenced inselection to theCD42CD81 phenotype but not in imma-
CD8 SP cells (Sawada et al., 1994; Siu et al., 1994),ture double-positive thymocytes. The enhancer also
CD8 down-regulation in T cells may similarly involvefunctions in gut intraepithelial lymphocytes that ex-
transcriptional silencing. In fact, the expression of bothpress CD8a but not CD8b, suggesting that it is specific
CD4 and CD8 is strongly repressed in hybrids formedfor CD8a expression. The tight correlation between
between CD41CD81 and CD42CD82 parental lymphomaactivation of this enhancer and the final step in positive
clones, suggesting that negative factors (or putative si-selection has important implications for understand-
lencing factors) in CD42CD82 cells regulate the expres-ing the mechanism of lineage commitment in thymo-
sion of both CD4 and CD8 (Wilkinson et al., 1991). Takencytes.
together, these results point to positive and negative
regulatory mechanisms for CD8 transcription.
Several candidate regulatory sequences for CD8 lin-Introduction
eage specificexpression have been previously reported.
Multiple binding sites for the T cell±restricted transcrip-The two major subsets of T lymphocytes in the periph-
tion factor GATA-3 have been identified upstream of theeral immune system express either the CD4 or the CD8
mouse CD8a gene (Landry et al., 1993). These GATA-3coreceptor and generally have a helper or cytotoxic phe-
binding sites coincide with CD8 lineage-specific DNasenotype, respectively. These single-positive (SP) cells de-
I hypersensitivity (DH) sites, and it has been shown thatvelop in the thymus from a common progenitor that
GATA-3 is able to transactivate a CAT-reporter con-expresses both CD4 and CD8 during a process known
struct containing these sites. It is unlikely that GATA-3as positive selection. Double-positive (DP) thymocytes
is a major mediator for subset±specific expression ofwith a T cell receptor (TCR) specific for major histocom-
CD8, however, since it is also expressed in CD4 SP Tpatibility complex (MHC) class II molecules develop to-
cells (Zheng and Flavell, 1997). Another study implicatedward the CD4 lineage, whereas DP cells with a TCR
the region approximately 300 bp upstream of thespecific for MHC class I develop toward the CD8 lineage
GATA-3 binding sites in the transcriptional down-regula-(Robey and Fowlkes, 1994; Fowlkes and Schweighoffer,
tion of the CD8a gene upon fusion with the BW51471995; Kisielow and von Boehmer, 1995; Guidos, 1996;
thymoma (Lee et al., 1994). The role of these elements inMarrack and Kappler, 1997).
vivo remains tobe addressed. A T cell±specific enhancerThe molecular mechanism underlying the develop-
has been mapped in the last intron of the human CD8a
mental choice toward either the helper or the cytotoxic
gene (Hambor et al., 1993). In transgenic mice, this en-
phenotype is not known (Davis and Littman, 1994; von
hancer directed expression of the human CD8a reporter
Boehmer, 1996). Since the expression of the CD4 or
gene in NK cells but not in T cells (Kieffer et al., 1996).
CD8 coreceptor proteins generally correlates with the
Since a subset of human NK cells expresses CD8a ho-
phenotype of the differentiated T cell, factors that regu-
modimers (Moebius et al., 1991), the intronic enhancer
late transcription of these genes probably also partici-
might be involved in the regulation of CD8 expression
pate in directing the development of the helper versus
in this cell type.
cytotoxic T cell lineages. An understanding of how the
We and others have previously failed to achieve high-
level, subset-specific expression of transgene genomic
fragments containing the human CD8a gene, suggest-³To whom correspondence should be addressed (e-mail: littman@
saturn.med.nyu.edu). ing that multiple elements, spread over the whole CD8
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locus, control the expression of the CD8a and CD8b CD8 Subset-Specific Expression of an hCD2
Reporter Gene in Peripheral Lymphocytesgenes (Kieffer et al., 1996; N. Lonberg et al., unpublished
The correlation between CD8 expression and the pres-data). Recently, Hostert et al. (1997) performed a com-
ence of the DH sites prompted us to test the role of thisprehensive DH study of the 80 kb murine CD8 locus and
intergenic segment in the regulation of CD8 expressionidentified four clusters of DH sites, three of which are
in vivo. We therefore developed a transgenic reporterspecific for thymocytes. By generating transgenic mice
construct (designated TG-a) in which the391 bp minimalwith a P1 clone containing the whole CD8 locus, they
murine CD8a promoter (Nakauchi et al., 1987) waswere able to achieve developmentally regulated, tissue-
cloned upstream of an expression cassette containingspecific and CD8 subset±specific expression of the
a murine CD4 splicing module (composite of the un-CD8 transgene. However, this study did not determine
translated exon I, part of intron I, and part of exon II)whether individual DH clusters or DH sites within these
linked to the hCD2 cDNA and the SV40 polyadenylationclusters are able to mediate expression.
signal (Sawada et al., 1994) (Figure 1C). Since most partsWe identified two DH sites that are specific for CD8-
of intron I aredeleted in the CD4 splicing module (includ-expressing cells and correspond to cluster III of Hostert
ing the CD4 silencer region), hCD2 can be expressed inet al. (1997). A genomic fragment containing the CD8-
both CD4 and CD8 SP T cells when appropriate regula-specific DH sites was tested for its ability to regulate
tory elements are present. The fragment containing bothexpression of a human CD2 (hCD2) reporter gene in
DH sites in the CD8 locus was isolated from a genomictransgenic mice. In these mice, hCD2 was expressed
129 library homozygous for the 7.6 kb BamHI RFLP (dataspecifically in CD8 SP thymocytes and peripheral CD8
not shown). This genomic 7.6 kb BamHI fragment waslineage T cells, but not in DP thymocytes. In addition,
then inserted upstream of the mCD8a promoter, therebyhCD2 expression was observed in IEL expressing CD8a
generating TG-b. These constructs were injected intohomodimers. These results indicate that we have identi-
fertilized (B6/D2) F2-mouse eggs to generate transgenicfied an enhancer that directs transcription of the CD8a
animals. Transgenic founders identified by Southerngene only in mature thymocytes and T cells. Further-
blotting of tail DNA were either analyzed directly or back-more, we provide evidence that the activity of this en-
crossed to C57BL/6 mice to generate transgenic lineshancer coincides with positive selection of CD8 lineage
that were then analyzed.thymocytes. These findings are interpreted in the con-
Expression of hCD2 was not observed in founders or
text of recent models that suggest that a specific signal
lines that had integrated TG-a, indicating that the CD8a
is required for DP thymocytes to commit to the CD8
promoter is not sufficient to direct expression of the
cytotoxic lineage.
reporter gene (Table 1). In contrast, four of five founders
and their progeny prepared with TG-b displayed high-
level expression of hCD2 in peripheral CD42CD81 T cellsResults
but not in CD41CD82 T cells (Table 1 and Figure 2A).
Furthermore, no expression was observed in B cellsIdentification of DH Sites
(data not shown). This suggested that the 7.6 kb geno-
To identify cis-acting elements that are involved in the
mic fragment contained a CD8 lineage T cell specific
regulation of CD8 gene expression, we conducted a
enhancer; alternatively, as observed in the CD4 gene,
study of DH sites (Gross and Garrard, 1988) in regions
this fragment could contain an enhancer plus a silencer
adjacent to the murine CD8a and CD8b genes. In earlier that shuts off expression in CD41 CD82 cells. To deter-
studies, we identified DH sites flanking the two genes, mine whether a silencer restricts expression of the re-
but, unlike the CD4 enhancer (Sawada and Littman, porter to the CD8 lineage, the 7.6 kb fragment was in-
1991), these had no significant enhancer activity in serted upstream of the CD4 enhancer and promoter
transfected cells (K. Chu and D. R. L., unpublished data) (construct c in Sawada et al., 1994). Transgenic mice
and corresponded to regions that failed to direct CD8 prepared with this construct expressed the hCD2 re-
expression in transgenic mice (N. Lonberg et al., unpub- porter in both CD4 and CD8 lineage cells, suggesting
lished data). Therefore we extended our search to a that the 7.6 kb fragment contains only a lineage-specific
region between the CD8b and CD8a genes and probed enhancer (data not shown).
for DH sites in CD42CD81 (1200M), CD41CD81 (AKR1), The percentage of CD8 SP cells expressing hCD2
and CD41CD82 (BOH4) T cell lines; in the B cell line varied between the TG-b transgenic lines and ranged
M12; and in NIH3T3 fibroblast cells. Two DH sites (desig- from 0.3% to 100%. Some founders transmitted this
nated HS-1 and HS-2) were identified in an approxi- variegated phenotype to F1 animals, whereas others
mately 9.0 kb genomic BamHI fragment only in cells that were mosaic, and lines derived from them showed a
expressed CD8 (e.g., 1200M and AKR1) (Figure 1B). The higher percentage of hCD2-expressing CD42CD81 T
probe used for Southern hybridization detected a BamHI cells. In the transgenic line TG-b#4, which expressed
restriction fragment length polymorphism (RFLP) of ei- hCD2 on all CD42CD81 T cells, about 5%±10% of CD4
ther a 9.0 kb fragment in 1200M and AKR1.G.1 cells or SP T cells also expressed hCD2, although at a 2.5-fold
of a 7.6 kb fragment in BO4H and M12 cells. NIH3T3 lower level compared to hCD2 in the CD8 SP population
cells appeared to be heterozygous for the BamHI RFLP, (Table 1 and Figure 2A). Similar observations were made
explaining the presence of both the 9.0 kb and the 7.6 in line TG-b#12, in which about 1.6% of CD4 SP cells
kb fragments. HS-1 and HS-2, which map approximately expressed hCD2 at 6-fold lower levels compared to CD8
19 and 15 kb upstream of the CD8a gene, respectively, SP T cells. The low-level expression in some CD41CD82
overlap with two DH sites in a region designated cluster T cells most likely reflects positional effects due to the
site of transgene integration.III by Hostert et al. (1997) (Figure 1A).
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Figure 1. DH Sites in the Murine CD8 Gene
and Corresponding Segments Used for Pre-
paring Transgenic Constructs
(A) (Top) Organization of the CD8 locus (after
Gorman et al., 1988, Hostert et al., 1997; our
unpublisheddata). Vertical bars, BamHI sites;
horizontal arrows, position and transcrip-
tional orientation of the CD8a and CD8b
genes. The arrangement of DH clusters II, III,
and IV is according to Hostert et al. (1997).
HS-1 and HS-2 represent the two CD8-spe-
cific DH sites identified in this study that are
identical to two of three DH sites (vertical
arrows) within cluster III. Bar with asterisk,
2.1 kb KpnI fragment used as a probe for
hybridization of the genomic blot.
(Bottom) Map of the genomic fragments used
for the generation of transgenic constructs
TG-b, TG-d, TG-e, TG-f, TG-g, and TG-h.
Light shaded areas, the approximate location
of the DH sites HS-1 and HS-2. Restriction
enzyme sites are BamHI (B), EcoRI (E), EcoRV
(EV), HindIII (H), KpnI (K), and XbaI (X). Only
sites relevant for the transgenic constructs
are shown.
(B) Nuclei from the cell lines indicated were
isolated and treated with increasing amounts
of DNase I. Subsequently genomic DNA was
isolated, BamHI digested, and transferred
ontoa gene screen membrane and hybridized
with the probe shown in Figure 1A. Lanes
1±6 for 1200M, BO4H, AKR1.G.1, and M12
included 0, 2, 4, 6, 8, and 16 mg/ml DNase I,
respectively, whereas for NIH3T3 cells 0, 2,
4, 6, and 8 mg/ml DNase I (lanes 1±5) were
used. Arrows, DH sites. The presence of ei-
ther a z9.0 kb BamHI fragment (in 1200M and
AKR1.G.1) or a z7.6 kb BamHI fragment (in
BO4H and M12) or both (NIH3T3) indicates a
BamHI RFLP recognized by the probe used
for Southern hybridization. Molecular size
markers (kilobases) are shown at right.
(C) Schematic representation of the trans-
genic reporter construct, in which genomic
fragments shown in Figure 1A were inserted
upstream from the CD8a promoter.
To test whether the CD8-specific enhancer works ex- (containing HS-2 and at least part of HS-1 on a 5 kb
KpnI±BamHI fragment; Figure 1A) expressed hCD2 atclusively in conjunction with the CD8 promoter or rather
as an independent cis-regulatory element, construct high levels in a CD8 subset±specific manner (Table 1
and Figure 2B). In these animals, no expression aboveTG-c was generated by linking the 7.6 kb genomic frag-
ment with the murine CD4 promoter (Sawada and Litt- background (defined by hCD2 antibody staining of non-
transgenic littermates) was observed in CD41CD82 Tman, 1991). The enhancerless CD4 promoter construct
does not mediate expression of hCD2 (Sawada et al., cells. To test the role of the DH sites individually, con-
structs TG-e and TG-f, both containing only HS-1 (either1994). Analyses of peripheral T cells from TG-c founders
and lines revealed that the 7.6 kb genomic element to- in 3.3 kb HindIII or in 3.5 kb BamHI±EcoRV fragments,
respectively) were generated. As shown in Table 1,gether with the CD4 promoter still functions as a CD8
SP subset±specific enhancer (Table 1 and Figure 2A). transgenic constructs containing HS-1 failed to mediate
expression of hCD2 in a high percentage of CD42CD81In addition, the enhancer functions in an orientation-
independent manner, since the genomic fragment was T cells. In 4 of 21 founders (TG-e#3 and TG-e#6, and
TG-f#9 and TG-f#36), however, a low but significant pop-inserted in the opposite orientation in TG-c compared
to that in TG-b. ulation (2%±4%) of CD8 SP T cells expressing hCD2
was observed (Table 1). Lines generated from some ofTo narrow down the genomic region mediating the
subset-specific expression of the hCD2 reporter gene, these founders (e.g., TG-e#3) showed an increase (10%)
in the CD42CD81 population that expressed hCD2,additional transgenic constructs containing overlapping
segments of the 7.6 kb fragment were generated (Figure whereas in others the proportion remained low (e.g.,
TG-f#36). This result indicates that fragments containing1A). Founders or lines of transgenes TG-d (containing
both DH sites on a 6 kb EcoRI±BamHI fragment) or TG-g HS-1 have a CD8 subset±specific activity, but that its
Immunity
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Table 1. hCD2 Expression on Peripheral CD41CD82 and CD42CD81 T Cells from Mice with Transgenes TG-a through TG-h
Founder CD41 T Cells CD81 T Cells
Construct Copy Number hCD21 (%) Mean Fluorescence hCD21 (%) Mean Fluorescence
TG-a 1* (10) 0 (Ð) 0 (Ð)
7* (8) 0 (Ð) 0 (Ð)
TG-b 2* (30) 0.3 (Ð) 56.7 (135.6)
3* (6) 0.1 (Ð) 6.5 (127.9)
4* (4) 5.7 (48.8) 99.9 (116.9)
7* (4) 0.3 (Ð) 0.3 (Ð)
12 (26) 1.4 (67.9) 27.7 (428.4)
TG-c 2* (7) 1.6 (65.1) 30.3 (201.8)
3 (2) 0.1 (Ð) 2.0 (22.5)
TG-d 3* (10) 0.4 (62.3) 40.0 (317.2)
9* (7) 0.2 (Ð) 2.7 (211.8)
11 (8) 0.2 (Ð) 3.0 (134.9)
13 (6) 0.9 (27.5) 12.9 (153.0)
14* (2) 0.1 (Ð) 85.2 (56.5)
TG-e 3 (10) 0.2 (Ð) 1.9 (96.6)
6 (6) 0.1 (Ð) 3.8 (34.9)
8 (4) 0 (Ð) 0 (Ð)
16 (4) 0.3 (Ð) 0.9 (49.6)
25 (7) 0.2 (Ð) 0.5 (61.0)
114 (5) 1.3 (19.3) 0 (Ð)
125 (10) 0 (Ð) 0.1 (Ð)
132 (14) 0.1 (Ð) 0.9 (133.2)
134 (2) 0.4 (24.7) 0 (Ð)
140 (10) 0.1 (Ð) 0.4 (137.8)
150 (3) 0.1 (Ð) 0.3 (Ð)
156 (8) 0.3 (Ð) 1.6 (29.5)
157 (2) 0.1 (Ð) 0.1 (Ð)
TG-f 2 (1) 0 (Ð) 0.5 (154.8)
9 (5) 0.2 (Ð) 3.1 (51.3)
14 (1) 0.1 (Ð) 0 (Ð)
24 (2) 0 (Ð) 0 (Ð)
33 (5) 0.1 (Ð) 0.6 (110.5)
36 (7) 0.1 (Ð) 1.9 (114.0)
46 (4) 0 (Ð) 0.6 (110.1)
52 (2) 0.4 (13.1) 0.2 (Ð)
TG-g 9 (6) 0.6 (26.2) 61.5 (69.3)
13 (5) 0.1 (Ð) 27.9 (44.7)
17 (6) 0.6 (124.2) 12.3 (167.6)
20 (8) 0.2 (Ð) 46.6 (72.0)
25 (14) 0.2 (Ð) 8.4 (157.6)
TG-h 10 (4) 0 (Ð) 1.6 (26.5)
15 (20) 0 (Ð) 0.2 (Ð)
16 (4) 0 (Ð) 0 (Ð)
25 (4) 0 (Ð) 0.1 (Ð)
27 (2) 0 (Ð) 0 (Ð)
28 (3) 0 (59.9) 0.4 (50.8)
30 (16) 0 (Ð) 1.2 (59.6)
35 (2) 0.1 (39.6) 0 (Ð)
37 (2) 0 (Ð) 0 (Ð)
38 (5) 0 (Ð) 1.0 (36.4)
40 (8) 0.1 (19.4) 0.4 (68.8)
Peripheral lymphocytes (from either lymph nodes or blood) were isolated and analyzed by three-color flow cytometry. The percentage of
hCD2-expressing cells (together with the mean fluorescence) in either the CD4 SP or the CD8 SP T cell compartment is shown. The copy
number of transgenes in each founder is indicated.
* A progeny was used for analysis.
activity is weak and highly susceptible to position ef- This indicates that a major cis-regulatory element is
located within the deleted 1 kb XbaI±BamHI fragment.fects.
To determine whether cis-acting sequences con- It remains to be determined whether HS-2 alone or in
combination with other sequences (including HS-1)taining HS-2 are required for enhancer function, we de-
leted a 1kb XbaI±BamHI fragment containing this DH within the 4 kb KpnI±XbaI fragment is required for opti-
mal enhancer function.site from the insert of TG-g, thereby generating con-
struct TG-h. Among the 11 TG-h founder animals ana-
lyzed, in only some there was a very low percentage of hCD2 Expression on IEL
On thymus-derived peripheral T cells, the CD8 moleculeCD42CD81 T cells expressing hCD2, in the same range
as observed for TG-e and TG-f (Table 1 and Figure 2). exists predominantly as a heterodimer formed by the
Mature CD8 Lineage Enhancer
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Figure 2. CD8 Subset-Specific Expression of an hCD2 Reporter in Peripheral Lymphocytes
Three-color flow cytometry analysis was performed on lymph node cells isolated from the transgenic lines indicated. Histograms show hCD2
expression on T cells gated either on the CD41 or CD81 population. Shown are representative gates for the CD41 and CD81 T cell population.
(A) Expression of hCD2 from constructs containing the 7.6 kb genomic fragment together with the mCD8a (TG-b) or the mCD4 promoter
(TG-c).
(B) Expression of hCD2 from constructs containing the mCD8a promoter together with subregions from the 7.6 kb genomic fragment. For
founders TG-g#17 and TG-h#28 and for the transgenic lines TG-b#4/9 (/9 indicates progeny #9), TG-c#2/2, and TG-d#14/2, Table 1 provides
the percentage of hCD2-expressing cells within the CD41 or CD81 population. TG-e#3/3 and TG-f#36/9 represent progeny from founders (TG-
e#3 and TG-f#36, respectively) included in Table 1.
CD8a and CD8b chains, whereas extrathymically de- reporter correlates with expression of CD8a in mature
peripheral T lymphocytes, including IEL, suggesting thatrived CD42CD81 T cells, such as the majority of intraepi-
thelial TCRgd and some TCRab T lymphocytes (IEL) of the enhancer is specific for the CD8a gene. This result
does not rule out the possibility that this enhancer isthe gut, express only CD8aa homodimers (Lefrancois,
1991; Moebius et al., 1991). Since CD8a and CD8b are also required for CD8b expression. However, additional
positive or negative elements would then be requiredlinked on mouse chromosome 6 (Gorman et al., 1988)
(Figure 1A), it is possible that the identified enhancer is to account for the differential expression of CD8b.
specific for directing expression of CD8a, CD8b, or both
genes. By analyzing CD8 SP T cells, one cannot distin- Expression Analysis during T Cell Development
guish among these possibilities. To examine whether the enhancer is also involved in
However, if the CD8 enhancer is specific for CD8a, the regulation of CD8 gene expression during T cell
one would expect expression of the transgenic hCD2 development, we analyzed hCD2 expression in thymo-
reporter on extrathymically derived IEL, unless the regu- cytes from transgenic animals that had subset-specific
latory elements responsible for CD8a expression are expression in the periphery (e.g., TG-b, TG-d, and TG-g).
different in thymus-derived T cells and extrathymically In contrast to similar CD4 enhancer and silencer report-
derived IEL. To test this, IEL from the gut were isolated ers (Sawada et al., 1994), hCD2 was expressed exclu-
and analyzed for the expression of hCD2. CD8aa1 IEL of sively in CD8 SP thymocytes, and not in theDP compart-
TCRgd (Figure 3A) and TCRab (data not shown) lineages ment (Figure 4). In addition, the proportion of CD8 SP
expressed hCD2 in transgenic lines obtained with TG-b, thymocytes expressing hCD2 was consistently lower
than the proportion in the mature peripheral CD8 lineageTG-c, TG-d and TG-g. hCD2 reporter expression was
also observed in CD8ab-expressing IEL (Figure 3B), cells. For example, in line TG-b#4, hCD2 was expressed
in 100% of peripheral CD42CD81 T cells but in onlywhich are almost exclusively of the TCRab lineage (Le-
francois, 1991). Thus, expression of the hCD2 transgenic 80%±90% of CD8 SP thymocytes.
Immunity
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Figure 3. hCD2 Expression on IEL
Intestinal IEL from the transgenic lines indicated were isolated and analyzed for hCD2 expression by three-color flow cytometry. (A) Histograms
show expression of hCD2 on TCRgd1CD8aa1 IEL. A representative gate is shown at left. (B) Expression of hCD2 on CD8aa1 and CD8ab1
subpopulations of IEL. Representative gates for the CD8aa1 and CD8ab1 population are shown at left.
The population of thymocytes that express CD8 can cells, CD4loCD81HSAloTCRabhi, indicates that these cells
were matureand had completed positive selection. Con-be subdivided into cells at multiple stages. DP cells
that undergo positive selection partially down-regulate sistent with the mature status of these cells, they also
up-regulated H-2Kb (Kisielow et al., 1984; Scollay andsurface CD4 and CD8 and then progress through
CD4loCD81 to CD42CD81 stages in the presence of Shortman, 1985) and CD5 (Takahama and Singer, 1992)
(data not shown). Similar surface phenotypes of hCD22MHC class I ligand. During final maturation, the thymo-
cytes up-regulate the level of TCR and down-regulate and hCD21 cells were observed within the CD42CD81
compartment (data not shown). These results demon-HSA expression (van Meerwijk and Germain, 1993). We
next analyzed hCD2 expression in these CD8 lineage strate that theCD8 enhancer described here is activated
only in the latest stage of CD8 SP differentiation.subsets to determine whether reporter gene transcrip-
tion correlates with the developmental stage. Analysis
of CD41CD81, CD4loCD81, and CD42CD81 thymocytes Discussion
showed a progressive increase in the percentage of
cells expressing the reporter gene, indicating a link be- In this study we describe the identification of an en-
hancer that directs expression of CD8 in vivo exclusivelytween enhancer activity and maturation of thymocytes
(Figure 5A). in mature thymocytes and T cells. This enhancer was
found to colocalize with two CD8 lineage-specific DHTo probe this further, we determined the develop-
mental status of hCD21 versus hCD22 cells within the sites in the region between the genes encoding the two
CD8 subunits. Genomic fragments containing both DHCD4loCD81 compartment by analyzing the expression
of TCRab, HSA, and CD69 on these cells. The CD4loCD81 sites directed expression of a reporter gene in CD8 SP
thymocytes and T cells as well as in IEL, but not in DPpopulation has been shown to contain thymocytes com-
mitted to the CD8 lineage (Lundberg et al., 1995; Suzuki thymocytes. The 7.6 kb BamHI fragment functioned in
an orientation-independent manner and with either theet al., 1995; Lucas and Germain, 1996). As shown in
Figure 5B, hCD22 cells were of the immature phenotype murine CD8a or the heterologous murine CD4 promoter,
indicating that it contains independent cis-acting regula-(CD4loCD81HSAhiTCRabint/hi), and a proportion of these
cells expressed CD69, indicating that they were in the tory elements that mediate expression of CD8 selec-
tively in mature T cells. In addition, up-regulation ofprocess of positive selection (Bendelac et al., 1992; Swat
et al., 1993). In contrast, thesurface phenotype of hCD21 reporter gene expression correlated with the transition
Mature CD8 Lineage Enhancer
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Figure 4. hCD2 Expression during Thymocyte Development
Thymocytes from the transgenic animals indicated were analyzed by three-color flow cytometry. Histograms show expression of hCD2 in the
thymocyte population. Representative gates for either the CD42CD82, CD41CD81, CD41CD82, or CD42CD81 population are shown at left.
of committed CD8 lineage cells from the HSAhiTCRint/hi IEL from the gut express CD8aa homodimers instead
(Jarry et al., 1990; Lefrancois, 1991). The expression ofto the HSAloTCRhi phenotype that marks completion of
positive selection. hCD2 on IEL of the CD8aa1TCRgd and TCRab lineages
(either of the CD8aa or CD8ab subtype) indicates thatRecently, four clustersof DH sites within 80 kb encom-
passing the murine CD8 locus were described. Trans- the enhancer is specific for the CD8a gene. However,
it remains possible that the enhancer region also hasgenic mice prepared with a large genomic fragment that
included all four DH clusters (three of which are specific an effect on the CD8b gene located upstream (relative
to its transcriptional orientation) of the CD8 enhancer.for thymocytes) exhibited appropriate expression of the
transgene in developing thymocytes and in peripheral This would imply that a silencer element may repress
expression of CD8b in IEL or that the CD8 enhancerT cells (Hostert et al., 1997). Expression of this large
transgene was found to be mosaic, most likely due to may function in conjunction with the CD8b promoter in
a cell type±restricted manner. A recent study suggestsposition-effect variegation (Festenstein et al., 1996),
prompting the authors to suggest that endogenous ex- that the CD8b gene may indeed be negatively regulated.
Transgenic mice prepared with a 95 kb human geno-pression of the CD8 genes might not be dependent on
the presence of a locus control region (Grosveld et al., mic DNA fragment that contained the entire CD8b gene
were shown to express hCD8b not only in CD8 SP cells1987; Greaves et al., 1989; Martin et al., 1996). By gener-
ating transgenic mice with HS-1 and HS-2, which over- and CD8ab1 IEL of the TCRab lineage, but also in
CD8aa1TCRab IEL (Kieffer et al.,1997). Whether expres-lapped two of the three thymocyte-specific DH sites
within cluster III described by Hostert et al. (1997), we sion in the CD8aa1TCRab population reflects the ab-
sence of a negatively acting element in the transgenealso observed mosaic patterns of transgene expression.
This was not surprising, considering that position-effect or is due to cross-species differences remains to be
determined.variegation was observed even with the large genomic
CD8 locus (Hostert et al., 1997). However, we cannot Maturation of thymocytes of the TCRab lineage in-
volves intricate regulation of the levels of cell surfaceexclude the possibility that the transgeneswould be less
susceptible to position effects if additional cis elements CD4 and CD8 at different stages of development (Kisie-
low and von Boehmer, 1995; Zuniga-Pflucker and Len-from the CD8 locus were included.
The majority of thymus-dependent, MHC class ardo, 1996). Double-negative thymocytes that express
a cell surface pre-TCR following productive rearrange-I±restricted CD42CD81 T cells express CD8ab hetero-
dimers on their surface, whereas a large population of ment of the TCRb gene undergo selection that is marked
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Figure 5. Onset of hCD2 Expression during
CD8 SP Thymocyte Development
Thymocytes from the transgenic line TG-b#4
were analyzed by four-color flow cytometry
for the expression of hCD2, HSA, TCRab, and
CD69.
(A) Histograms showing hCD2 expression
levels on different subpopulations of CD81
thymocytes. Gating areas for the CD41CD81,
CD4loCD81, and CD42CD81 populations are
shown at left. hCD22 and hCD21 regions in
the CD4loCD81 histogram indicate represen-
tative gates used for further analysis, pre-
sented in Figure 5B.
(B) Expression of HSA, TCRab, and CD69 on
total CD4loCD81 thymocytes and on subsets
of this population that are either negative or
positive for hCD2 expression, as defined in
Figure 5A.
by initial expression of low levels of CD8 and a subse- this model, stimulation of DP thymocytes in vivo or in
organ culture with anti-CD3 monoclonal antibodies re-quent increase in both CD4 and CD8 levels to give rise
to DP cells. During subsequent MHC ligand-depen- sults in the appearance of CD4 SP cells but not CD8
SP cells (Groves et al., 1995; Kearse et al., 1995; Cibottident positive selection, DP cells commit to either the
CD41CD82 T helper lineage or the CD42CD81 cytotoxic et al., 1997). In addition, deficiency of ZAP-70 in humans
results in complete loss of CD8 lineage cells, but onlylineage. The mechanism by which DP thymocytes differ-
entiate into mature SP cells remains controversial (von in a partial defect in maturation of CD4 lineage cells,
suggesting that there may be more stringent signalingBoehmer, 1996). We and others have proposed that
commitment to the CD4 or CD8 lineage is stochastic requirements for positive selection of CD8 lineage cells
(Arpaia et al., 1994; A. C. Chan et al., 1994; Elder et al.,(Chan et al., 1993; Davis et al., 1993; van Meerwijk and
Germain, 1993) and is followed by selection of thymo- 1994).
The correlation between the mature CD8 enhancercytes that have coreceptors with MHC specificity that
matches that of the TCR. More recent studies, using in activity and positive selection can now be interpreted
in the context of current models of thymocyte lineagevitro and in vivo analyses of highly purified thymocyte
subpopulations, favor a more complex mechanism in- commitment and may provide important insight into the
underlying mechanisms. A major implication of our re-volving an intermediateCD41CD8lo population that gives
rise to both the CD4 and CD8 SP lineages (Lucas et al., sults is that there must exist distinct cis-acting elements
that direct CD8 expression solely in DP cells. It is there-1995; Lundberg et al., 1995; Suzuki et al., 1995; Benven-
iste et al., 1996; Lucas and Germain, 1996). Differentia- fore likely that after DP thymocytes receive TCR-medi-
ated signals to initiate positive selection, they down-tion of the intermediate cells appears to require initiation
of positive selection by TCR signaling in response to regulate this early CD8 enhancer (E8DP). An additional
signal provided by interaction with MHC class I (possiblyeither MHC class I or class II; however, subsequent
differentiation toward the CD8 lineage, by way of Notch-mediated) may then activate both the CD4 si-
lencer (S4) and the mature CD8 SP enhancer (E8SP) de-CD4loCD81 intermediate cells, occurs only if MHC class
I is present (Suzuki et al., 1995; Benveniste et al., 1996). scribed here, resulting in the transition from CD41CD8lo
to CD4loCD8lo to CD4loCD81 to CD42CD81 cells (FigureThis has led to the suggestion that in the absence of
an instructional signal requiring TCR (and probably CD8) 6). The gradual increase in the proportion of hCD21 cells
observed as thymocytes progress from DP to CD8 SPinteraction with class I, thymocytes default to the CD4
lineage. It has been proposed that delivery of such a cells (Figure 5A) is consistent with this notion. In cells
that fail to interact with class I, extinction of E8DP functionsignal also involves activation of Notch, which has been
shown to bias DP cells to commit to the CD8 lineage in the face of unopposed CD4 enhancer activity would
mark commitment to the CD4 SP T helper lineage.when it is expressed as a constitutively active protein
in transgenic mice (Robey et al., 1996). Consistent with An obvious paradox is presented by the finding that
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Figure 6. Model for CD8 Enhancer Function
during Differentiation of DP to SP Thymo-
cytes
Positive selection is postulated to initiate
down-regulation of a putative CD8 enhancer
specific for DP cells (E8DP). In the absence of
an additional signal, cells default to the CD4
lineage. If the thymocytes receive a CD8-spe-
cific instructional signal (possibly involving
Notch), they activate the CD4 silencer (S4) and
the mature CD8 enhancer (E8SP). The CD4 en-
hancer is postulated to be active throughout
this sequence of differentiation.
E8SP is activated only in mature (TCRhiHSAlo), and not in developing T cell (S. H. Chan et al., 1994; Corbella et
al., 1994; Robey et al., 1994). Thus, activation of trans-immature (TCRintHSAhi), CD4loCD81 thymocytes (Figure
5B). It therefore remains unclear how CD8 is initially acting factors that regulate the CD4 silencer and the
mature CD8 enhancer is likely to involve componentsdown-regulated, upon receipt of the positive selection
signal, and then reexpressed at high levels prior to acti- that are common to a cytotoxic T cell differentiation
program. To bridge our gap in understanding the naturevation of E8SP (Figure 6). We favor a model in which down-
regulation of CD8 (in CD41CD8lo cells) may be a transient of CD8 lineage-specific signaling and the commitment
to the cytotoxic program, it will be necessary to identifyposttranslational effect, due to endocytosis following
MHC class I engagement by the TCR. In such a model, the key nuclear factors. Elucidation of the mechanism
of CD8 gene regulation will therefore provide importantE8DP in class I specific thymocytes would remain active
longer than in the cells of the same surface phenotype insights into how functionally distinct T lymphocytes
arise from multipotential precursors.destined to default to the CD4 lineage. Alternatively, this
result may reflect a requirement for additional cis-acting
Experimental Proceduressequences, absent in our transgenic constructs, to initi-
ate E8SP activity earlier in development. Resolution of
Cell Lines and Culturethis paradox will require the use of the putative E8DP The B cell line M12, the murine CD4 SP T cell hybridoma BO4H, and
elements in experiments similar to those described here. the murine 1200M thymoma (CD8 SP) were gifts from R. Grosschedl
Our results suggest that CD4 silencer activity is initi- (University of California, San Francisco), N. Shastri (University of
ated before that of E8SP (Figure 6). This observation must California, Berkeley), and J. Allison (University of California, Berke-
ley), respectively. The murine thymoma AKR.1.G.1 (CD41CD81) andbe interpreted with caution, however, because recent
NIH3T3 fibroblasts were from the American Type Culture Collection.studies suggest that there may also be distinct CD4
All cell lines were grown in Dulbecco's modified Eagle's medium,enhancer functions in DP versus CD4 SP thymocytes
supplemented with 10% fetal calf serum (FCS) and antibiotics.
(Salmon et al., 1996; Adlam et al., 1997). Lucas and
Germain (1996) have shown that suitable TCR engage- DH Site Analysis
ment of DP thymocytes leads initially to down-regulation Nuclei were isolated and subjected to DNase I as described by
Landry et al. (1993). In brief, 6 3 107 cells were washed once inof both CD4 and CD8 (CD4loCD8loTCRint), prior to reex-
phosphate-buffered saline and then lysed on ice for 5 min in 1 mlpression of CD4 (CD41CD8loTCRint/hi). This apparently
of reticulysate standard buffer (RSB) (10 mM Tris-HCl [pH 7.5], 10transient decrease in CD4 expression may also be due
mM NaCl, and 3 mM MgCl2) supplemented with 0.5% NP-40. Theto a switch in CD4 enhancer usage. Although it is clear nuclei were pelleted and washed once with 1 ml of RSB and resus-
that CD4 enhancer function is intact in CD8 SP cells pended in 600 ml of RSB. Nuclei (100 ml) were added to Eppendorf
(Sawada et al., 1994), further studies are required to tubes containing different amounts of DNase I (final concentrations
0, 2, 4, 6, 8, and 16 mg/ml) and incubated at 378C for 2 min. Thedetermine whether there are additional elements in-
DNase I reaction was stopped by adding 100 ml of RSB containing 10volved in temporal regulation of CD4 expression during
mM EDTA and 2% sodium dodecyl sulfate, and 40 mg of proteinase Kthymopoiesis.
was added. After 2±5 hr of incubation at 378C, the DNA was extracted
As noted above, the element(s) responsible for ex- with phenol and chloroform and precipitated with ethanol. Genomic
pression of CD8 in the DP population remain tobe identi- DNA (20 mg) was digested with BamHI and analyzed by Southern
fied. It will be important to determine whether DNA se- blotting (Sambrook et al., 1989).
quences within the peripheral enhancer, E8SP, contribute
Generation of the Transgenesto the function of E8DP, or whether E8DP is a distinct and
Transgene TG-a was generated from the mCD4 reporter constructindependent enhancer. Future experiments, including
(Sawada et al., 1994) by replacement of the XbaI±KpnI CD4 promoterdeletion of E8SP by homologous recombination, should fragment with a XbaI±KpnI polylinker and subsequent insertion of
help to answer this question. the PCR-amplified murine CD8a promoter (nucleotides 1±391; Na-
The transcriptional regulation of the CD4 and CD8 kauchi et al., 1987). A BamHI fragment containing the two DH sites
was isolated from a 129 genomic library (Stratagene) and subclonedgenes is tightly linked to the functional program of the
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into pBS. The final transgenic constructs were derived either by R.H. (1992). Activation events during thymic selection. J. Exp. Med.
175, 731±742.direct cloning of genomic subfragment into TG-a or by means of
pBS-CD8a promoter-genomic fragment intermediates. Details of Benveniste, P., Knowles, G., and Cohen, A. (1996). CD8/CD4 lineage
the protocol can be obtained upon request. commitment occurs by an instructional/default process followed by
positive selection. Eur. J. Immunol. 26, 461±471.
Generation of Transgenic Mice Chan, S.H., Cosgrove, D., Waltzinger, C., Benoist, C., and Mathis,
F2 eggs of (B6/D2) mice were injected with the different transgenes D. (1993). Another view of the selective model of thymocyte selec-
according to standard procedures (Hogan et al., 1994). Founders tion. Cell 73, 225±236.
were indentified by Southern blotting with a probe from the CD4
Chan, A.C., Kadlecek, T.A., Elder, M.E., Filipovich, A.H., Kuo, W.L.,
splicing module (Sawada et al., 1994), and transgene copy number
Iwashima, M., Parslow, T.G., andWeiss, A. (1994). ZAP-70 deficiency
was determined by phosphorimager analysis. Transgenic founders
in an autosomal recessive form of severe combined immunodefi-
were either analyzed directly or crossed to C57BL/6 mice to gener-
ciency. Science 264, 1599±1601.ate lines. All mice analyzed were aged 4±16 weeks.
Chan, S.H., Waltzinger, C., Baron, A., Benoist, C., and Mathis, D.
(1994). Role of coreceptors in positiveselection and lineage commit-Flow Cytometric Analysis and Antibodies
ment. EMBO J. 13, 4482±4489.Thymocytes, spleen, and lymph nodes were removed from eutha-
Cibotti, R., Punt, J.A., Dash, K.S., Sharrow, S.O., and Singer, A.nized mice and placed into 60 mm tissue culture dishes containing
(1997). Surface molecules that drive T cell development in vitro inphosphate-buffered saline supplemented with 2% FCS and 0.1%
the absence of thymic epithelium and in the absence of lineage-sodium azide (staining buffer). Cell suspensions were made by pass-
specific signals. Immunity 6, 245±255.ing the tissue through a 70 mm nylon cell strainer. The cell suspen-
sion was washed once in staining buffer, and flow cytometry was Corbella, P., Moskophidis, D., Spanopoulou, E., Mamalaki, C., To-
performed by staining 5±10 3 105 cells with the appropriate antibod- laini, M., Itano, A., Lans, D., Baltimore, D., Robey, E., and Kioussis,
ies on ice for 30 min. Cells were washed and either analyzed or D. (1994). Functional commitment to helper T cell lineage precedes
stained with secondary antibodies on ice for another 30 min. Cells positive selection and is independent of T cell receptor MHC speci-
were analyzed using a Becton Dickinson FACScan flow cytometer ficity. Immunity 1, 269±276.
and CellQuest software. The following antibodies were used: fluo- Davis, C.B., Killeen, N., Crooks, M.E., Raulet, D., and Littman, D.R.
rescein isothiocyanate (FITC)±conjugated anti-hCD2 (Leu 5b) from (1993). Evidence for a stochastic mechanism in the differentiation
Becton Dickinson; FITC- or biotin (bio)±conjugated anti-hCD2 (clone of mature subsets of T lymphocytes. Cell 73, 237±247.
G11), phycoerythrin (PE)±conjugated anti-mCD8a (CT-CD8a), FITC-
Davis, C.B., and Littman, D.R. (1994). Thymocyte lineage commit-
anti-mCD8b (CT-CD8b), TC-anti-mCD4 (CT-CD4), PE- or bio-anti-
ment: is it instructed or stochastic? Curr. Opin. Immunol. 6, 266±272.
mCD3 (Clone 500-A2), and TC-streptavidin from Caltag; and APC-
Elder, M.E., Lin, D., Clever, J., Chan, A.C., Hope, T.J., Weiss, A.,anti-mCD8 (53±6.7), APC-anti-mCD4 (RM4±5), FITC- or bio-anti-HSA
and Parslow, T.G. (1994). Human severe combined immunodefi-(M1/69), bio-anti-CD69 (H1.2F3), bio-anti-mTCRab (H57±597), bio-
ciency due to a defect in ZAP-70, a T cell tyrosine kinase. Scienceanti-mTCRgd (GL3), bio-anti mCD3e (145±2C11),bio-anti-mCD5 (53±
264, 1596±1599.7.3), PE-anti-mH-2Kb (AF6±88.5), and PE-streptavidin from Phar-
Festenstein, R., Tolaini, M., Corbella, P., Mamalaki, C., Parrington,mingen.
J., Fox, M., Miliou, A., Jones, M., and Kioussis, D. (1996). Locus
control region function and heterochromatin-induced position effectIsolation of IEL from the Gut
variegation. Science 271, 1123±1125.To isolate IEL, the gut was removed from the peritonium of eutha-
nized mice andthe lumen was washed by flushing with RPMI supple- Fowlkes, B.J., and Schweighoffer, E. (1995). Positive selection of T
mented with 2% FCS and antibiotics. The gut was turned inside- cells. Curr. Opin. Immunol. 7, 188±195.
out over polyethylene tubing and incubated in 200 ml of RPMI (10% Gorman, S.D., Sun, Y.H., Zamoyska, R., and Parnes, J.R. (1988).
FCS, antibiotics, and 20 mM HEPES) at 378C for 45 min in a shaker Molecular linkage of the Ly-3 and Ly-2 genes. Requirement of Ly-2
with low agitation to release the IEL from the intestinal epithelium for Ly-3 surface expression. J. Immunol. 140, 3646±3653.
into the medium. The lymphocytes were pelleted by centrifugation Greaves, D.R., Wilson, F.D., Lang, G., and Kioussis,D. (1989). Human
at 2000 rpm for 10 min at room temperature, resuspended in me- CD2 39-flanking sequences confer high-level, T cell-specific, posi-
dium, and purified by 37% Percoll centrifugation (1750 rpm for 30 tion-independent gene expression in transgenic mice. Cell 56,
min at room temperature). After two washings with staining buffer, 979±986.
the IEL were first incubated for 5 min on ice with Fc-block (Phar-
Gross, D.S., and Garrard, W.T. (1988). Nuclease hypersensitive sitesmingen) and subsequently stained with the appropriate antibodies.
in chromatin. Annu. Rev. Biochem. 57, 159±197.
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